Scientists discovered a promising cure for HIV infection through a therapeutical vaccine.
Washington D.C. is embarking on the nation's first campaign to enlighten black women about a new HIV preventive measure.
At present, Truvada is the only name effective pill to prevent HIV infection. It has to be taken daily. Researchers are now doing clinical trials on long-acting Cabotegravir, which may turn out to be the AIDS vaccine everybody has been waiting for. People will need to take a single shot of Cabotegravir every two months for HIV prevention.
The HIV research community is optimistic about the promising "shock and kill" approach to eradicating HIV.
Research findings have discovered that these drugs contribute to HIV-associated neurocognitive disorders, or HAND, which can be manifested as confusion, forgetfulness, with behavioral and motor changes.
Research shows that addiction therapy helps lower subtance dependence among those with HIV.
